Research
ARU leads £2.5m project to save languages
New project aims to REVIVE the Cornish language.
Rethinking Innovation 2025
Inspiring talks, discussions and networking to advance your thinking on sustainability, innovation and technology management. ...
DNA damage can last unrepaired for years, changing our view of mutations
While most known types of DNA damage are fixed by our cells’ in-house repair mechanisms, some forms of DNA damage evade repair and can persist for many years, new research shows. This means that the damage has multiple chances to generate harmful mutations, which can lead to cancer. ...
UK public would pay more tax for extra nurses
Survey of 2,000 UK adults also suggests nursing is one of the most rewarding jobs. ...
Milner Therapeutics Institute announces 2025 Consortium Call
The 2025 Milner Therapeutics Consortium Call opened on 13 January, with an exciting new focus around pharma-led challenges. ...
Study reveals gender equality benefits everyone
Research across 62 nations finds sexism is problematic for men as well as women.
First UK survey aims to fill Botox knowledge gap
Anglia Ruskin University is examining people’s experiences, including side effects. ...
Free Virtual Workshop: Search and Access Structural Chemistry Data With the CSD Python API
If you want to search for crystal structures in the Cambridge Structural Database (CSD) to gain insights and understand trends programmatically then this free, 90-minute, hands-on workshop is for you! ...
Human ‘Domainome’ reveals root cause of inherited conditions
The largest catalogue of human protein variants to date has revealed that protein destabilisation is the main driver of inherited genetic conditions and paves the way for precision medicine and AI-driven treatments. ...
Addressing nitrosamine analysis challenges in pharmaceuticals with the ATNA
Detecting nitrosamines in pharmaceutical products is essential for maintaining safety and ensuring regulatory compliance. Following high-profile recalls involving nitrosamine impurities, such as N-Nitrosodimethylamine (NDMA), regulatory bodies like the FDA and EMA now require pharmaceut...